# Metastasis-directed Therapy in Castration-refractory Prostate Cancer

> **NCT04222634** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 18 (estimated)

## Conditions studied

- Castration-resistant Prostate Cancer

## Interventions

- **OTHER:** Radiotherapy (SBRT) and/or surgery (metastasectomy)

## Key facts

- **NCT ID:** NCT04222634
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-12-27
- **Primary completion:** 2023-07-25
- **Final completion:** 2030-01-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2023-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04222634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04222634, "Metastasis-directed Therapy in Castration-refractory Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04222634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*